440 related articles for article (PubMed ID: 32374043)
21. Crosslinking-guided geometry of a complete CXC receptor-chemokine complex and the basis of chemokine subfamily selectivity.
Ngo T; Stephens BS; Gustavsson M; Holden LG; Abagyan R; Handel TM; Kufareva I
PLoS Biol; 2020 Apr; 18(4):e3000656. PubMed ID: 32271748
[TBL] [Abstract][Full Text] [Related]
22. The relevance of the chemokine receptor ACKR3/CXCR7 on CXCL12-mediated effects in cancers with a focus on virus-related cancers.
Freitas C; Desnoyer A; Meuris F; Bachelerie F; Balabanian K; Machelon V
Cytokine Growth Factor Rev; 2014 Jun; 25(3):307-16. PubMed ID: 24853339
[TBL] [Abstract][Full Text] [Related]
23. Allosteric peptide regulators of chemokine receptors CXCR4 and CXCR7.
Ehrlich A; Ray P; Luker KE; Lolis EJ; Luker GD
Biochem Pharmacol; 2013 Nov; 86(9):1263-71. PubMed ID: 23973527
[TBL] [Abstract][Full Text] [Related]
24. Structural basis for chemokine recognition by a G protein-coupled receptor and implications for receptor activation.
Ziarek JJ; Kleist AB; London N; Raveh B; Montpas N; Bonneterre J; St-Onge G; DiCosmo-Ponticello CJ; Koplinski CA; Roy I; Stephens B; Thelen S; Veldkamp CT; Coffman FD; Cohen MC; Dwinell MB; Thelen M; Peterson FC; Heveker N; Volkman BF
Sci Signal; 2017 Mar; 10(471):. PubMed ID: 28325822
[TBL] [Abstract][Full Text] [Related]
25. CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies.
Khare T; Bissonnette M; Khare S
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298991
[TBL] [Abstract][Full Text] [Related]
26. Chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3 regulate vascular α₁-adrenergic receptor function.
Bach HH; Wong YM; Tripathi A; Nevins AM; Gamelli RL; Volkman BF; Byron KL; Majetschak M
Mol Med; 2014 Oct; 20(1):435-47. PubMed ID: 25032954
[TBL] [Abstract][Full Text] [Related]
27. Rapid uptake and degradation of CXCL12 depend on CXCR7 carboxyl-terminal serine/threonine residues.
Hoffmann F; Müller W; Schütz D; Penfold ME; Wong YH; Schulz S; Stumm R
J Biol Chem; 2012 Aug; 287(34):28362-77. PubMed ID: 22736769
[TBL] [Abstract][Full Text] [Related]
28. Differential Involvement of ACKR3 C-Tail in β-Arrestin Recruitment, Trafficking and Internalization.
Zarca A; Perez C; van den Bor J; Bebelman JP; Heuninck J; de Jonker RJF; Durroux T; Vischer HF; Siderius M; Smit MJ
Cells; 2021 Mar; 10(3):. PubMed ID: 33799570
[No Abstract] [Full Text] [Related]
29. New Insights into Mechanisms and Functions of Chemokine (C-X-C Motif) Receptor 4 Heteromerization in Vascular Smooth Muscle.
Evans AE; Tripathi A; LaPorte HM; Brueggemann LI; Singh AK; Albee LJ; Byron KL; Tarasova NI; Volkman BF; Cho TY; Gaponenko V; Majetschak M
Int J Mol Sci; 2016 Jun; 17(5):. PubMed ID: 27331810
[TBL] [Abstract][Full Text] [Related]
30. G protein activation via chemokine (C-X-C motif) receptor 4 and α
Gao X; Majetschak M
FEBS Lett; 2023 Aug; 597(15):2017-2027. PubMed ID: 37395117
[TBL] [Abstract][Full Text] [Related]
31. Interaction of chemokine receptor CXCR4 in monomeric and dimeric state with its endogenous ligand CXCL12: coarse-grained simulations identify differences.
Cutolo P; Basdevant N; Bernadat G; Bachelerie F; Ha-Duong T
J Biomol Struct Dyn; 2017 Feb; 35(2):399-412. PubMed ID: 26813575
[TBL] [Abstract][Full Text] [Related]
32. Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer.
Nazari A; Khorramdelazad H; Hassanshahi G
Int J Clin Oncol; 2017 Dec; 22(6):991-1000. PubMed ID: 29022185
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological Characterization and Radiolabeling of VUF15485, a High-Affinity Small-Molecule Agonist for the Atypical Chemokine Receptor ACKR3.
Zarca AM; Adlere I; Viciano CP; Arimont-Segura M; Meyrath M; Simon IA; Bebelman JP; Laan D; Custers HGJ; Janssen E; Versteegh KL; Buzink MCML; Nesheva DN; Bosma R; de Esch IJP; Vischer HF; Wijtmans M; Szpakowska M; Chevigné A; Hoffmann C; de Graaf C; Zarzycka BA; Windhorst AD; Smit MJ; Leurs R
Mol Pharmacol; 2024 Mar; 105(4):301-312. PubMed ID: 38346795
[TBL] [Abstract][Full Text] [Related]
34. Effects of cognate, non-cognate and synthetic CXCR4 and ACKR3 ligands on human lung endothelial cell barrier function.
Cheng YH; Eby JM; LaPorte HM; Volkman BF; Majetschak M
PLoS One; 2017; 12(11):e0187949. PubMed ID: 29125867
[TBL] [Abstract][Full Text] [Related]
35. Production of Chemokine/Chemokine Receptor Complexes for Structural Biophysical Studies.
Gustavsson M; Zheng Y; Handel TM
Methods Enzymol; 2016; 570():233-60. PubMed ID: 26921949
[TBL] [Abstract][Full Text] [Related]
36. Cathepsin K cleavage of SDF-1α inhibits its chemotactic activity towards glioblastoma stem-like cells.
Hira VV; Verbovšek U; Breznik B; Srdič M; Novinec M; Kakar H; Wormer J; der Swaan BV; Lenarčič B; Juliano L; Mehta S; Van Noorden CJ; Lah TT
Biochim Biophys Acta Mol Cell Res; 2017 Mar; 1864(3):594-603. PubMed ID: 28040478
[TBL] [Abstract][Full Text] [Related]
37. Structures of atypical chemokine receptor 3 reveal the basis for its promiscuity and signaling bias.
Yen YC; Schafer CT; Gustavsson M; Eberle SA; Dominik PK; Deneka D; Zhang P; Schall TJ; Kossiakoff AA; Tesmer JJG; Handel TM
Sci Adv; 2022 Jul; 8(28):eabn8063. PubMed ID: 35857509
[TBL] [Abstract][Full Text] [Related]
38. Class A G protein-coupled receptors assemble into functional higher-order hetero-oligomers.
Gao X; Enten GA; DeSantis AJ; Majetschak M
FEBS Lett; 2021 Jul; 595(14):1863-1875. PubMed ID: 34032285
[TBL] [Abstract][Full Text] [Related]
39. CXCR7, CXCR4, and Their Ligand Expression Profile in Traumatic Brain Injury.
Mousessian AS; Nunes da Silva CP; Oba-Shinjo SM; Kolias AG; Paiva WS; Nagahashi Marie SK
World Neurosurg; 2021 Mar; 147():e16-e24. PubMed ID: 33189916
[TBL] [Abstract][Full Text] [Related]
40. Signal transmission through the CXC chemokine receptor 4 (CXCR4) transmembrane helices.
Wescott MP; Kufareva I; Paes C; Goodman JR; Thaker Y; Puffer BA; Berdougo E; Rucker JB; Handel TM; Doranz BJ
Proc Natl Acad Sci U S A; 2016 Aug; 113(35):9928-33. PubMed ID: 27543332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
